BioCentury
ARTICLE | Company News

Baxter pharmaceuticals, biosimilars, cancer news

October 27, 2014 7:00 AM UTC

This year, Baxter plans to begin work on a new global innovation and R&D center in Cambridge, Massachusetts, for the Baxalta Inc. biopharma company that will emerge from the split of the company's business. The company expects to bring about 400 R&D employees to the center as well as business development, cancer and biosimilars teams. The R&D positions that will relocate to the new center are based in California and Europe. Baxalta will maintain other R&D operations in Vienna and will have its corporate headquarters in northern Illinois. Baxalta will continue to transition work to the new 200,000 square foot facility over the next two years to ensure continuity of current programs. ...